(Q45968869)

18 December 2017

title

Cost-effectiveness of varenicline for smoking cessation. (English)

1 reference

18 December 2017

author name string

Hans Keiding

series ordinal

1

1 reference

18 December 2017

publication date

1 June 2009

1 reference

18 December 2017

Expert Review of Pharmacoeconomics & Outcomes Research

published in

1 reference

18 December 2017

volume

9

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

215-221

1 reference

18 December 2017

Regional, disease specific patterns of smoking-attributable mortality in 2000.

cites work

1 reference

Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke

21 January 2018

1 reference

Pharmacotherapy for smoking cessation

21 January 2018

1 reference

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation

21 January 2018

1 reference

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy

21 January 2018

1 reference

Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison

21 January 2018

1 reference

The health care costs of smoking

21 January 2018

1 reference

Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers

21 January 2018

1 reference

Development of the health and economic consequences of smoking interactive model

21 January 2018

1 reference

Varenicline for tobacco dependence

21 January 2018

1 reference

Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.

21 January 2018

1 reference

Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan

21 January 2018

1 reference

Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia

21 January 2018

1 reference

Modern medical support for smoking cessation

21 January 2018

1 reference

Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERP.09.19

1 reference

18 December 2017

1 reference

18 December 2017